GENEVA, Oct. 19 -- PFIZER INC. (66 Hudson Boulevard EastNew York, New York 10001-2192) filed a patent application (PCT/IB2025/053787) for "NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS" on Apr 10, 2025. With publication no. WO/2025/215579, the details related to the patent application was published on Oct 16, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CHOI, Chulho (c/o Pfizer Inc.445 Eastern Point RoadBuilding 98Groton, Connecticut 06340), FENSOME, Andrew (c/o Pfizer Inc.610 Main StreetCambridge, Massachusetts 02139), FUTATSUGI, Kentaro (c/o Pfizer Inc.610 Main StreetCambridge, Massa...